RxDoctor Payments Data

Quang Luu, MD

Otolaryngology · Mission Viejo, CANPI 1861528663

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (30.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Synthes GmbH at 48.6% of the total. Reporting peaked in 2024 at $6,706 and has fallen 64.0% since, to $2,415 in 2025. Among otolaryngology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,776in general payments, 2019–2025

Across 88 payments — averaging $202.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Synthes GmbH$9K
  • Intuitive Surgical$8K
  • Optinose US, Inc.$214
  • Stryker$204
  • GSK$199
  • Johnson & Johnson$165
  • plus $809 from 18 others

What the payments were for

  • Consulting fees$1,5008%
  • Speaking & faculty fees$4,50025%
  • Travel & lodging$3,99222%
  • Food & beverage$2,28413%
  • Education$5,50031%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,776 in reported general payments places this provider in the 95th percentile of 1,021 otolaryngology providers in California.

See all otolaryngology providers in California →

Medicare billing

Part B allowed, 2024
$232,430
Medicare patients
541
Services billed
1,699

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth14$1,794
Ipratropium Bromide48$1,425
Triamcinolone Acetonide16$836
Doxycycline Monohydrate22$748
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav58$540
Ofloxacin17$490
Methylprednisolone50$365
Mometasone Furoate22$282
Mupirocin41$241
Clindamycin Hcl12$232
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen40$223
Cephalexin17$149
Prednisone14$96
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen27$95
Clotrimazole14$91

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Mission Viejo

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →